Effects of protamine hydrochloride from chum salmon milt on lipid metabolism in rats

Protamine is a basic protein whose sulfate is used in medical applications as a carrier for injectable insulin and as a heparin antagonist, while its hydrochloride is used as an antibacterial ingredient for some food products. We previously showed that protamine hydrochloride derived from chum salmon milt inhibited pancreatic lipase and reduced plasma triacylglycerol levels in an oral fat tolerance test in humans. The present study evaluated the effect of chum protamine hydrochloride on lipid metabolism in rats. The single oral administration of protamine hydrochloride (500 mg/kg) reduced plasma triacylglycerol levels in a corn oil tolerance test, and repeated oral administration at a dose of 0, 150, 500, or 1,500 mg/kg with a high fat diet for 7 weeks significantly reduced body weight gain, liver weight, and epididymal adipose tissue, whereas total calorie intakes were not significantly different. These findings could be caused by the suppression of lipid digestibility leading to a significant increase in fecal lipid excretion due to the fact that protamine hydrochloride could bind with bile acids to make a complex that is difficult to digest. Protamine hydrochloride, with a considerable history as food, can be considered to be promising as an anti-obesity functional food material.     

Dietary salmon milt deoxyribonucleic acid prevents hepatosteatosis in mice

With the increased incidence of lifestyle-related diseases, prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing at an unprecedented rate, leading to rising interest in studying the role of functional foods in its prevention. This study demonstrated the efficacy of salmon milt deoxyribonucleic acid (SM DNA) in preventing liver dysfunction in a diet-induced obesity model. Seven-week-old male C57BL/6J mice were fed normal diet (ND), high-fat diet (HFD), and HFD supplemented with 3% SM DNA (HFD?+?SM DNA) for 12 weeks. Increased body weight, fat-to-body weight ratio, and fat accumulation in HFD-fed mice demonstrated successful establishment of an obesity model. The HFD group showed increased alanine aminotransferase (ALT) levels, a marker of liver function, and NAFLD activity score (NAS) based on histological observations showed steatosis and mild inflammation but no fibrosis, indicating NAFLD but no nonalcoholic steatohepatitis. In the HFD?+?SM DNA group, the improved superoxide dismutase activity and NAFLD activity score suggested that SM DNA prevented liver dysfunction while maintaining antioxidant capacity and suppressing intrahepatocyte fat droplet formation. SM DNA attenuated fat accumulation in the liver and improved hepatic function. This study explored the potential of SM DNA as a functional food to prevent NAFLD and other visceral obesity-related diseases.

     

Effect of dietary glucosylceramide from sea cucumber on plasma and liver lipids in cholesterol-fed mice

Various physiological functions of dietary glucosylceramides (GlcCer) have been reported, such as preventing colon cancer and improving skin barrier function. One potential GlcCer source used as a foodstuff is sea cucumber. In this study, our objective was to determine the effect of dietary GlcCer prepared from sea cucumber on plasma and liver lipids in cholesterol-fed mice. ICR mice were fed four different diets (control diet, sea cucumber GlcCer supplemented diet, high cholesterol supplemented diet, and high cholesterol + sea cucumber GlcCer supplemented diet). Dietary GlcCer decreased total cholesterol significantly in ICR mice. The mRNA expression of LDL receptor was increased significantly, while the expression of the gene CYP7A1, which is involved in bile acid formation, was decreased significantly compared with the control (diet without cholesterol). These results suggest that the expression of the cholesterol homeostasis gene in liver is modulated due to the cholesterol lowering effect of dietary GlcCer.     

Effect of the liquid form of traditional Chinese medicine,Hozen-S,on gastric motility in dogs

Juzen-taiho-to, a traditional Chinese herbal medicine, is used for patients with anorexia and fatigue in human medicine. In our previous study, granulated Juzen-taiho-to improved vincristine-induced gastrointestinal adverse effects through increasing gastric motility in dogs. As the effect of Hozen-S, the sweet liquid form of Juzen-taiho-to, on dog gastric motility has not been investigated, we examined the effect of administration of Hozen-S on gastric motility. Furthermore, we assessed dog plasma ghrelin level to further elucidate the mechanism of the effect of Hozen-S on gastric contraction. Finally, we assessed the palatability of Hozen-S compared to granulated Juzen-taiho-to and its effect on body weight in dogs. Administration of Hozen-S significantly increased gastric motility, plasma ghrelin concentration, and body weight. A palatability evaluation revealed that the dogs preferred Hozen-S to granulated Juzen-taiho-to. In conclusion, Hozen-S administration to dogs promoted gastric motility by raising plasma ghrelin levels. Considering these functional and palatability data, Hozen-S may replace granulated type Juzen-taiho-to and become a prominent traditional Chinese veterinary medicament.